Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The authors reply.
Tuttle KR, Bosch-Traberg H, Cherney DZI, Hadjadj S, Mosenzon O, Rasmussen S, Bain SC. Tuttle KR, et al. Kidney Int. 2023 Sep;104(3):619. doi: 10.1016/j.kint.2023.06.008. Kidney Int. 2023. PMID: 37599024 No abstract available.
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
Doria A, Galecki AT, Spino C, Pop-Busui R, Cherney DZ, Lingvay I, Parsa A, Rossing P, Sigal RJ, Afkarian M, Aronson R, Caramori ML, Crandall JP, de Boer IH, Elliott TG, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Maahs DM, McGill JB, Molitch ME, Perkins BA, Polsky S, Pragnell M, Robiner WN, Rosas SE, Senior P, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M; PERL Study Group. Doria A, et al. Among authors: tuttle kr. N Engl J Med. 2020 Jun 25;382(26):2493-2503. doi: 10.1056/NEJMoa1916624. N Engl J Med. 2020. PMID: 32579810 Free PMC article. Clinical Trial.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
Mind the gap in kidney care: translating what we know into what we do.
Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A; World Kidney Day Joint Steering Committee. Luyckx VA, et al. Among authors: tuttle kr. Kidney Int. 2024 Mar;105(3):406-417. doi: 10.1016/j.kint.2023.12.003. Kidney Int. 2024. PMID: 38375622 Free article.
Author Response to "Insulin Dosing Safety in CKD".
Alicic RZ, Neumiller JJ, Galindo RJ, Tuttle KR. Alicic RZ, et al. Among authors: tuttle kr. Kidney Int Rep. 2023 Feb 2;8(4):947-948. doi: 10.1016/j.ekir.2023.01.033. eCollection 2023 Apr. Kidney Int Rep. 2023. PMID: 37069975 Free PMC article. No abstract available.
Tirzepatide and potential use for metabolically healthy obesity.
Copur S, Tanriover C, Yavuz F, Tuttle KR, Kanbay M. Copur S, et al. Among authors: tuttle kr. Eur J Intern Med. 2023 Jul;113:1-5. doi: 10.1016/j.ejim.2023.05.012. Epub 2023 May 12. Eur J Intern Med. 2023. PMID: 37183081 Review.
288 results